These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10353266

  • 1. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
    Sahu A, Rawal N, Pangburn MK.
    Biochem Pharmacol; 1999 Jun 15; 57(12):1439-46. PubMed ID: 10353266
    [Abstract] [Full Text] [Related]

  • 2. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 15; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 3. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
    Peake PW, Pussell BA, Martyn P, Timmermans V, Charlesworth JA.
    Int J Immunopharmacol; 1991 Mar 15; 13(7):853-7. PubMed ID: 1761351
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1979 Nov 15; 76(11):5867-71. PubMed ID: 293688
    [Abstract] [Full Text] [Related]

  • 5. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1981 Sep 01; 154(3):856-67. PubMed ID: 6912277
    [Abstract] [Full Text] [Related]

  • 6. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.
    Pangburn MK, Müller-Eberhard HJ.
    Ann N Y Acad Sci; 1983 Sep 01; 421():291-8. PubMed ID: 6586103
    [Abstract] [Full Text] [Related]

  • 7. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1971-5. PubMed ID: 273923
    [Abstract] [Full Text] [Related]

  • 8. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 9. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
    Englberger W, Hadding U, Etschenberg E, Graf E, Leyck S, Winkelmann J, Parnham MJ.
    Int J Immunopharmacol; 1988 Jun 01; 10(6):729-37. PubMed ID: 3198307
    [Abstract] [Full Text] [Related]

  • 10. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
    Waldo FB, Forristal J, Beischel L, West CD.
    J Clin Invest; 1985 Jun 01; 75(6):1786-95. PubMed ID: 3159752
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of classical C5 convertase in the complement system by factor H.
    Ito S, Tamura N.
    Immunology; 1983 Dec 01; 50(4):631-5. PubMed ID: 6228516
    [Abstract] [Full Text] [Related]

  • 12. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 13. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK, Müller-Eberhard HJ.
    J Exp Med; 1980 Oct 01; 152(4):1102-14. PubMed ID: 6903192
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 15. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3.
    Sahu A, Pangburn MK.
    Biochem Pharmacol; 1996 Mar 22; 51(6):797-804. PubMed ID: 8602875
    [Abstract] [Full Text] [Related]

  • 16. [Binding of activated C3b component with complement effector].
    Kozlov LV, Rostovtseva LI, Lomaka TS, Sutovskaia NS.
    Bioorg Khim; 1985 Jun 22; 11(6):762-8. PubMed ID: 3849970
    [Abstract] [Full Text] [Related]

  • 17. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H, Kinoshita T, Kim YU, Takata-Kozono Y, Tsunasawa S, Sakiyama F, Takeda J, Hong K, Inoue K.
    J Biol Chem; 1990 Aug 25; 265(24):14444-9. PubMed ID: 2387864
    [Abstract] [Full Text] [Related]

  • 18. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N, Pangburn M.
    J Immunol; 2001 Feb 15; 166(4):2635-42. PubMed ID: 11160326
    [Abstract] [Full Text] [Related]

  • 19. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T, Takata Y, Kozono H, Takeda J, Hong KS, Inoue K.
    J Immunol; 1988 Dec 01; 141(11):3895-901. PubMed ID: 3183384
    [Abstract] [Full Text] [Related]

  • 20. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    Kim YU, Carroll MC, Isenman DE, Nonaka M, Pramoonjago P, Takeda J, Inoue K, Kinoshita T.
    J Biol Chem; 1992 Feb 25; 267(6):4171-6. PubMed ID: 1740458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.